POSA354 Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients with FGFR2 Fusions/Rearrangements: Results from the Foenix-CCA2 Study
Abstract
Authors
JA Bridgewater A Hollebecque J Furuse L Goyal F Meric-Bernstam RS Epstein R Morlock T Salimi V Wacheck M Liu K Benhadji JW Valle